Taken together our evidence suggests ChAc as a novel disorder of proteostasis related to impaired autophagy with accumulation of neurotoxic proteins, supporting the rational to target active Lyn as a novel therapeutic option for ChAc. The gene discussed is LYN; the disease is chorea-acanthocytosis.